IOL Chemicals & Pharmaceuticals Limited is an Indian-based pharmaceutical company engaged in the manufacturing and marketing of bulk drugs and organic chemicals. The company has a diverse product portfolio, including Ibuprofen, Metformin, Lamotrigine, and various other APIs and intermediates used in the pharmaceutical, food, and animal feed industries.
- IOL Chemicals & Pharmaceuticals Limited reported Total Income for Q4 FY23 of ₹595.94 Crore up from ₹579.42 Crore year on year, a growth of 2.8%.
- Total Expenses for Q4 FY23 of ₹508.90 Crore down from ₹540.71 Crore year on year, a decline of 5.9%.
- Consolidated Net Profit of ₹64.78 Crore, up 117.7% from ₹29.76 Crore in the same quarter of the previous year.
- The Earnings per Share is ₹11.03, up from ₹5.07 in the same quarter of the previous year.